A Phase I Study to Evaluate the Safety of the the Recombinant Norovirus Hexavalent Vaccine in Healthy Subjects

Condition:   Gastroenteritis Interventions:   Biological: Recombinant Norovirus Hexavalent Vaccine;   Other: Matching Placebo Sponsors:   Syneos Health;   Chengdu Kanghua Biological products Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials